Efficacy of BIC/F/TAF versus standard of care in the treatment of new HIV infection diagnoses in the context of 'test and treat'
Latest Information Update: 12 Feb 2024
At a glance
- Drugs Bictegravir/emtricitabine/tenofovir alafenamide (Primary) ; Cobicistat/darunavir/emtricitabine/tenofovir alafenamide
- Indications HIV-1 infections
- Focus Therapeutic Use
- Acronyms The BIC T&T
Most Recent Events
- 07 Feb 2024 Status changed from active, no longer recruiting to completed.
- 18 Apr 2023 Planned End Date changed from 31 Jul 2022 to 31 Jul 2023.
- 18 Apr 2023 Planned primary completion date changed from 31 Jul 2022 to 31 Jul 2023.